Retinal vein occlusion (RVO) is a major cause of vision loss. Of the two main types of RVO, branch retinal vein occlusion (BRVO) is 4 to 6 times more prevalent than central retinal vein occlusion (CRVO). A basic risk factor for RVO is advancing age. Further risk factors include systemic conditions like hypertension, arteriosclerosis, diabetes mellitus, hyperlipidemia, vascular cerebral stroke, blood hyperviscosity, and thrombophilia. A strong risk factor for RVO is the metabolic syndrome (hypertension, diabetes mellitus, and hyperlipidemia). Individuals with end-organ damage caused by diabetes mellitus and hypertension have greatly increased risk for RVO. Socioeconomic status seems to be a risk factor too. American blacks are more often diagnosed with RVO than non-Hispanic whites. Females are, according to some studies, at lower risk than men. The role of thrombophilic risk factors in RVO is still controversial. Congenital thrombophilic diseases like factor V Leiden mutation, hyperhomocysteinemia and anticardiolipin antibodies increase the risk of RVO. Cigarette smoking also increases the risk of RVO as do systemic inflammatory conditions like vasculitis and Behcet disease. Ophthalmic risk factors for RVO are ocular hypertension and glaucoma, higher ocular perfusion pressure, and changes in the retinal arteries.
Highly macroporous semisynthetic cryogel microcarriers can be synthesized for culturing stem cells and neuronal type cells. Growth factors loaded to heparin-containing microcarriers show near zero-order release kinetics and cell-loaded microcarriers can be injected through a fine gauge cannula without negative effect on the cells. These carriers can be applied for cell transplantation applications.
The Lakagígar eruption in Iceland during 1783 was followed by the severe winter of 1783/1784, which was characterised by low temperatures, frozen soils, icebound watercourses and high rates of snow accumulation across much of Europe. Sudden warming coupled with rainfall led to rapid snowmelt, resulting in a series of flooding phases across much of Europe. The first phase of flooding occurred in late December 1783-early January 1784 in England, France, the Low Countries and historical Hungary. The second phase at the turn of February-March 1784 was of greater extent, generated by the melting of an unusually large accumulation of snow and river ice, affecting catchments across France and Central Europe (where it is still considered as one of the most disastrous known floods), throughout the Danube catchment and in southeast Central Europe. The third and final phase of flooding occurred mainly in historical Hungary during late March and early April 1784. The different impacts and consequences of the above floods on both local and regional scales were reflected in the economic and societal responses, material damage and human losses. The winter of 1783/1784 can be considered as typical, if severe, for the Little Ice Age period across much of Europe.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.